Alcon Total Assets 2011-2026 | ALC

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Alcon

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.6 B	30.3 B	29.6 B	29.2 B	28 B	27.6 B	27.7 B	27.1 B	27.4 B	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
31.6 B	27.1 B	28.7 B

Quarterly Total Assets Alcon

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	28 B	-	27.8 B	-	27.6 B	-	27.5 B	-	27.7 B	-	27.8 B	-	27.1 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
28 B	27.1 B	27.6 B

Total Assets of other stocks in the Medical instruments industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	261 K	-	-	$ 810 M	USA
Becton, Dickinson and Company BDX	55.3 B	$ 154.51	-1.17 %	$ 44.4 B	USA
Luminex Corporation LMNX	825 M	-	-	$ 1.75 B	USA
Akers Biosciences, Inc. AKER	10.9 M	-	-9.52 %	$ 20.6 M	USA
Repligen Corporation RGEN	2.83 B	$ 117.78	-0.46 %	$ 6.56 M	USA
Antares Pharma, Inc. ATRS	213 M	-	-	$ 955 M	USA
Ekso Bionics Holdings EKSO	20.1 M	$ 9.4	-11.74 %	$ 22.8 M	USA
Cantel Medical Corp. CMD	2.07 B	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	192 M	-	-	$ 282 M	USA
Hill-Rom Holdings, Inc. HRC	4.67 B	-	-0.05 %	$ 10.3 B	USA
Haemonetics Corporation HAE	2.45 B	$ 56.83	1.05 %	$ 2.86 B	USA
ICU Medical ICUI	4.05 B	$ 123.31	-1.53 %	$ 3.04 B	USA
Varian Medical Systems, Inc. VAR	4.46 B	-	-0.02 %	$ 16.3 B	USA
Intuitive Surgical ISRG	20.5 B	$ 452.07	-2.67 %	$ 161 B	USA
Harvard Bioscience HBIO	80.1 M	$ 5.2	2.16 %	$ 231 M	USA
Isoray ISR	267 M	-	0.03 %	$ 108 M	USA
AngioDynamics ANGO	280 M	$ 10.31	-13.65 %	$ 421 M	USA
Repro Med Systems KRMD	28.2 M	$ 4.32	1.17 %	$ 200 M	USA
AtriCure ATRC	654 M	$ 29.07	2.68 %	$ 1.39 B	USA
Pulse Biosciences PLSE	94.5 M	$ 23.0	-0.13 %	$ 1.55 B	USA
InfuSystem Holdings INFU	99.4 M	$ 9.29	-0.11 %	$ 192 M	USA
Masimo Corporation MASI	2.63 B	$ 178.59	0.33 %	$ 9.52 B	USA
iRhythm Technologies IRTC	1.02 B	$ 116.8	-1.2 %	$ 3.74 B	USA
Merit Medical Systems MMSI	2.69 B	$ 67.7	-0.78 %	$ 4 B	USA
BioLife Solutions BLFS	399 M	$ 19.51	1.14 %	$ 899 M	USA
electroCore ECOR	18.7 M	$ 6.8	3.03 %	$ 57.7 K	USA
STERIS plc STE	10.1 B	$ 218.71	-0.56 %	$ 21.6 B	USA
Teleflex Incorporated TFX	6.95 B	$ 117.81	-0.52 %	$ 5.26 B	USA
Utah Medical Products UTMD	123 M	$ 63.12	0.4 %	$ 205 M	USA
OraSure Technologies OSUR	403 M	$ 3.08	0.98 %	$ 226 M	USA
West Pharmaceutical Services WST	4.27 B	$ 254.8	0.82 %	$ 18.4 B	USA
DENTSPLY SIRONA XRAY	5.43 B	$ 11.63	-0.26 %	$ 2.32 B	USA
Glaukos Corporation GKOS	940 M	$ 112.77	0.12 %	$ 5.46 B	USA
ResMed RMD	5.1 B	$ 224.09	0.56 %	$ 32.7 B	USA
Predictive Oncology POAI	52.9 M	-	-	$ 31.1 M	USA
Baxter International BAX	20.1 B	$ 16.68	-0.6 %	$ 8.56 B	USA
NeuroMetrix NURO	15.3 M	-	5.05 %	$ 9.02 M	USA
STAAR Surgical Company STAA	452 M	$ 20.21	4.55 %	$ 1 B	USA
Stereotaxis STXS	52.3 M	$ 1.87	1.08 %	$ 170 M	USA
The Cooper Companies COO	12.4 B	$ 70.17	-1.76 %	$ 14 B	USA
LeMaitre Vascular LMAT	616 M	$ 108.49	-0.24 %	$ 2.46 B	USA
Microbot Medical MBOT	81.5 M	$ 2.4	1.27 %	$ 110 M	Israel
Nephros NEPH	11.9 M	$ 2.87	-2.21 %	$ 29.8 M	USA
Envista Holdings Corporation NVST	5.68 B	$ 25.81	-0.35 %	$ 4.34 B	USA
Milestone Scientific MLSS	7.81 M	$ 0.28	-4.86 %	$ 23 M	USA
Pro-Dex PDEX	61.2 M	$ 51.67	1.33 %	$ 170 M	USA
Retractable Technologies RVP	143 M	$ 0.69	2.99 %	$ 20.7 M	USA